OBJECTIVE: To determine whether the phosphorescent probe Oxyphor R2 (a palladium porphyrin dendrimer) becomes extravasated within normotensive skeletal muscle, R2 perfusion and washout studies were performed using a perfused rat hindlimb preparation. METHODS: Phosphorescence signals were monitored in tibialis anterior muscles after 35 min of R2 blood perfusion and across a subsequent washout period that included vasodilation (sodium nitroprusside, SNP, approximately 3 x 10(-2) M). RESULTS: Two responses were evident: Group 1 (n = 4)--Inflowing blood pressure and vascular conductance remained stable close to initial values and subsequently a marked vasodilation was evident with SNP (vascular conductance; R2 blood perfusion, 0.096 +/- 0.005; washout, pre-SNP, 0.085 +/- 0.005, post-SNP, 0.110 +/- 0.005 mL/min/mmHg, p <.05, for pre- vs. post-SNP). Baseline phosphorescence signals could be monitored up to 99 +/- 36 s post-SNP when the phosphorescence signal disappeared. For these muscles, palladium content was undetectable. Group 2 (n = 3)--Inflowing blood pressure increased 112% and vascular conductance fell approximately 50%. These hindlimbs were unresponsive to SNP, phosphorescence signal was undiminished by washout and SNP, and muscles became edematous. CONCLUSIONS: These results suggest that in normotensive muscle (i.e., Group 1 above), extravasation of phosphorescent probe R2 over 35 min of perfusion is insufficient to yield a detectable phosphorescence signal in skeletal muscle.
OBJECTIVE: To determine whether the phosphorescent probe Oxyphor R2 (a palladium porphyrin dendrimer) becomes extravasated within normotensive skeletal muscle, R2 perfusion and washout studies were performed using a perfused rat hindlimb preparation. METHODS: Phosphorescence signals were monitored in tibialis anterior muscles after 35 min of R2 blood perfusion and across a subsequent washout period that included vasodilation (sodium nitroprusside, SNP, approximately 3 x 10(-2) M). RESULTS: Two responses were evident: Group 1 (n = 4)--Inflowing blood pressure and vascular conductance remained stable close to initial values and subsequently a marked vasodilation was evident with SNP (vascular conductance; R2 blood perfusion, 0.096 +/- 0.005; washout, pre-SNP, 0.085 +/- 0.005, post-SNP, 0.110 +/- 0.005 mL/min/mmHg, p <.05, for pre- vs. post-SNP). Baseline phosphorescence signals could be monitored up to 99 +/- 36 s post-SNP when the phosphorescence signal disappeared. For these muscles, palladium content was undetectable. Group 2 (n = 3)--Inflowing blood pressure increased 112% and vascular conductance fell approximately 50%. These hindlimbs were unresponsive to SNP, phosphorescence signal was undiminished by washout and SNP, and muscles became edematous. CONCLUSIONS: These results suggest that in normotensive muscle (i.e., Group 1 above), extravasation of phosphorescent probe R2 over 35 min of perfusion is insufficient to yield a detectable phosphorescence signal in skeletal muscle.
Authors: Rick Bezemer; Dirk J Faber; Emre Almac; Jeroen Kalkman; Matthieu Legrand; Michal Heger; Can Ince Journal: Med Biol Eng Comput Date: 2010-11-03 Impact factor: 2.602
Authors: Daniel M Hirai; Jesse C Craig; Trenton D Colburn; Hiroaki Eshima; Yutaka Kano; Timothy I Musch; David C Poole Journal: J Appl Physiol (1985) Date: 2019-08-01
Authors: Scott K Ferguson; Daniel M Hirai; Steven W Copp; Clark T Holdsworth; Jason D Allen; Andrew M Jones; Timothy I Musch; David C Poole Journal: Nitric Oxide Date: 2014-04-21 Impact factor: 4.427
Authors: Clark T Holdsworth; Scott K Ferguson; Trenton D Colburn; Alexander J Fees; Jesse C Craig; Daniel M Hirai; David C Poole; Timothy I Musch Journal: Respir Physiol Neurobiol Date: 2017-01-22 Impact factor: 1.931
Authors: Scott K Ferguson; Daniel M Hirai; Steven W Copp; Clark T Holdsworth; Jason D Allen; Andrew M Jones; Timothy I Musch; David C Poole Journal: Respir Physiol Neurobiol Date: 2013-04-11 Impact factor: 1.931
Authors: Robert T Davis; Christian S Bruells; John N Stabley; Danielle J McCullough; Scott K Powers; Bradley J Behnke Journal: Crit Care Med Date: 2012-10 Impact factor: 7.598